Who is sponsoring NCT03125226?

NCT03125226 is sponsored by University of Washington.

What condition does NCT03125226 study?

NCT03125226 studies Bladder Carcinoma.

What drugs are being tested in NCT03125226?

Interventions: Polyethylene Glycol Hydrogel.

What is the status of NCT03125226?

NCT03125226 is currently COMPLETED.

Last reviewed 2021-02-25 · How we verify

TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer

NCT03125226 NA COMPLETED Results posted

This pilot clinical trial studies how well TracelT hydrogel works in localizing bladder tumors in patients undergoing radiation therapy for bladder cancer. TracelT hydrogel marks the location of a bladder tumor and makes it more visible during imaging tests. Using TracelT hydrogel tissue marker may help doctors learn more about tumor location and altering radiation dosage for bladder cancer.

Details

Lead sponsor	University of Washington
Phase	NA
Status	COMPLETED
Enrolment	12
Start date	Thu Oct 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Bladder Carcinoma

Interventions

Polyethylene Glycol Hydrogel

Countries

United States